the RespiRx™, today announced the first patient was dosed in its Phase 1 clinical trial evaluating RespiRx™ Nicotine Inhaler (QN-01) as a smoking cessation therapy in the U.S. Smoking ...

Inhaler: peak plasma concentrations of 49ng ... Nasal Spray antagonized by nasal vasoconstrictors (eg, xylometazoline). Smoking cessation potentiates theophylline, insulin, β-blockers ...

Smoking causes lung disease ... Relievers are often administered using a device called an inhaler. This lets you breathe the medicine in through your mouth and directly into your lungs.

Inhalers may be prescribed to people who have a variety of health conditions both chronic and acute, including asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. If you're new ...

“The most important thing everyone with COPD can do is to stop smoking, but there are also inhalers which can help prevent flare ups and also help to open up their airways.” “Pulmonary ...

Two-thirds of referred patients to a new smoking cessation service have quit smoking within the programme's first year. Royal Papworth Hospital in Cambridge said 450 people were helped to quit within ...